System and method for testing blood vessel access using powered fluid injector systems

US12002560B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12002560-B2
Application numberUS-201917043883-A
CountryUS
Kind codeB2
Filing dateApr 8, 2019
Priority dateApr 10, 2018
Publication dateJun 4, 2024
Grant dateJun 4, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A fluid injector system has a controller for operably controlling the injection of contrast and/or saline into a patient. The controller allows a user to program a diagnostic injection procedure having one or more phases according to which the contrast and/or saline will be injected into the patient so as to effect enhancement of a region thereof during an imaging procedure. It further allows the user to program a test injection procedure to be performed prior to the diagnostic injection procedure. The test injection procedure is implementable as: (a) a variable single phase test injection in which the rate at which the saline is to be delivered is selectable prior to and may be varied during performance thereof; and/or (b) a multi-phase test injection in which the rate at which the saline is to be delivered is selectable for each phase of the multi-phase test injection prior to performance thereof.

First claim

Opening claim text (preview).

We claim: 1. A fluid injector system comprising: a controller operably associated with at least one drive member by which at least one fluid contained within at least one fluid container is injectable into a patient, the controller including a programming system for enabling programming of at least one diagnostic injection procedure comprising at least one diagnostic injection phase according to which the at least one fluid is to be injected into the patient so as to effect enhancement of at least one region of interest thereof over a scan duration of a diagnostic imaging procedure; and the programming system for further enabling programming of a test injection procedure to be performed prior to the diagnostic injection procedure, wherein the test injection procedure is implementable as: a variable single phase test injection in which a flow rate at which the at least one fluid is to be delivered is selectable prior to performance of the variable single phase test injection and may be varied during performance of the variable single phase test injection. 2. The fluid injector system according to claim 1 , wherein the test injection procedure is further implementable as at least one of a multi-phase test injection in which the flow rate at which the at least one fluid is to be delivered is selectable for each phase of the multi-phase test injection prior to performance of the multi-phase test injection, and a fixed single phase test injection in which the flow rate at which the at least one fluid is to be delivered and the volume of the at least one fluid to be delivered are fixed. 3. The fluid injector system according to claim 1 , wherein the at least one fluid to be delivered during the variable single phase test injection is saline. 4. The fluid injector system according to claim 1 , wherein, for the variable single phase test injection, a volume of the at least one fluid to be delivered is selectable prior to performance of the variable single phase test injection. 5. The fluid injector system according to claim 2 , wherein, for the multi-phase test injection, a volume of the at least one fluid to be delivered is selectable prior to performance of the multi-phase test injection. 6. The fluid injector system according to claim 2 , wherein, for the multi-phase test injection, a volume of the at least one fluid to be delivered is different for each phase of the multi-phase test injection. 7. The fluid injector system according to claim 2 , wherein, for the multi-phase test injection, the flow rate at which the at least one fluid is to be delivered is different for each phase of the multi-phase test injection. 8. The fluid injector system according to claim 1 , wherein the flow rate at which the at least one fluid is to be delivered during performance of the variable single phase test injection is varied by varying a speed of the at least one drive member. 9. The fluid injector system according to claim 8 , wherein the speed of the at least one drive member is varied via manual input using a control element. 10. The fluid injector system according to claim 1 , wherein the programming system is further configured to enable adjusting the flow rate at which the at least one fluid is to be delivered during the at least one diagnostic injection phase based on a desired flow rate determined during performance of the variable single phase test injection. 11. The fluid injector system according to claim 2 , wherein the multi-phase test injection comprises at least a first phase having a first flow rate and a second phase following the first phase, the second phase having a second flow rate. 12. The fluid injector system according to claim 11 , wherein the second flow rate is different from the first flow rate. 13. A computer program product for enabling programming of a test injection procedure to be performed using a fluid injector system prior to a diagnostic injection procedure, the computer program product comprising at least one non-transitory computer-readable medium comprising one or more instructions that, when executed by at least one processor, cause the at least one processor to: enable a user, via the fluid injector system, to select the test injection procedure to be performed as a variable single phase test injection such that upon selecting the variable single phase test injection, a flow rate at which at least one fluid is to be delivered during the variable single phase test injection is selectable prior to performance of the variable single phase test injection and may be varied during performance of the variable single phase test injection. 14. The computer program product according to claim 13 , wherein the one or more instructions, when executed by at least one processor, further cause the at least one processor to enable the user, via the fluid injector system, to select a multi-phase test injection such that, upon selecting the multi-phase test injection, a flow rate at which at least one fluid is to be delivered during the multi-phase test injection is selectable for each phase of the multi-phase test injection prior to performance of the multi-phase test injection, or select a fixed single phase test injection such that, upon selecting the fixed single phase test injection, a flow rate at which at least one fluid is to be delivered during the fixed single phase test injection and a volume of the at least one fluid to be delivered during the fixed single phase test injection are fixed. 15. The computer program product according to claim 13 , wherein the at least one fluid to be delivered during at least one of the variable single phase test injection and the multi-phase test injection is saline. 16. The computer program product according to claim 13 , wherein, for the variable single phase test injection, a volume of the at least one fluid to be delivered is selectable prior to performance of the variable single phase test injection. 17. The computer program product according to claim 14 , wherein, for the multi-phase test injection, a volume of the at least one fluid to be delivered is selectable prior to performance of the multi-phase test injection. 18. The computer program product according to claim 14 , wherein, for the multi-phase test injection, a volume of the at least one fluid to be delivered is different for each phase of the multi-phase test injection. 19. The computer program product according to claim 14 , wherein, for the multi-phase test injection, the flow rate at which the at least one fluid is to be delivered is different for each phase of the multi-phase test injection. 20. The computer program product according to claim 13 , wherein the flow rate at which the at least one fluid is to be delivered during performance of the variable single phase test injection is varied by varying a speed of at least one drive member by which the at least one fluid contained within at least one fluid container is injectable into a patient. 21. The computer program product according to claim 20 , wherein the speed of the at least one drive member is varied via manual input using a control element. 22. The computer program product according to claim 13 , wherein the one or more instructions, when executed by at least one processor, are further configured to enable adjusting the flow rate at which the at least one fluid is to be delivered during the at least one diagnostic injection phase based on a desired flow rate determined during performance of the variable single phas

Assignees

Inventors

Classifications

  • G16H20/17Primary

    delivered via infusion or injection · CPC title

  • controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths (infusion of multiple fluids without using a controller A61M5/1407) · CPC title

  • for local operation · CPC title

  • Measuring or controlling the flow rate · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12002560B2 cover?
A fluid injector system has a controller for operably controlling the injection of contrast and/or saline into a patient. The controller allows a user to program a diagnostic injection procedure having one or more phases according to which the contrast and/or saline will be injected into the patient so as to effect enhancement of a region thereof during an imaging procedure. It further allows t…
Who is the assignee on this patent?
Bayer Healthcare Llc
What technology area does this patent fall under?
Primary CPC classification G16H20/17. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).